BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  COVID-19 Research: Paxlovid Disappoints in Standard-Risk Setting, Nasal Spray Offers New Hope

  Biopharma has been stepping up research and drug development against COVID-19 -though results haven’t always been encouraging. Here are the latest stories from this space:

  June 15, 2022

   · 

  3 min read

   · 

  Tristan Manalac
• 

  Drug Development

  Immunic Touts Favorable Phase II Results for MS Treatment

  Immunic released favorable updated results for the Phase II EMPhASIS clinical trial investigating the safety and efficacy of vidofludimus calcium to treat relapsing-remitting multiple sclerosis.

  June 15, 2022

   · 

  3 min read

   · 

  Jazmine Colatriano, M.S.
• 

  Policy

  Biotech Industry Seeks Congressional Greenlight for NOL Sales

  Industry lobbyists urge Congress to approve a plan that will allow companies not yet generating revenue from their assets to sell NOL carryforwards to larger companies.

  June 15, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  FDA

  Study: FDA Approves Cancer Drugs Eight Months Earlier than European Regulators

  A recent study found that over a span of ten years, the FDA approved cancer drugs approximately eight months earlier than the same drugs were greenlit by the European Commission (EC).

  June 15, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Oxford University Researchers Identify Gene Linked to Chronic Pain

  Researchers at Oxford University have identified a gene linked to pain. The discovery opens possibilities to develop drugs or gene therapies to help treat patients who suffer from chronic pain.

  June 15, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  Global Roundup: Clover’s COVID-19 Vaccine Booster Reaches Phase III

  Clover dosed the first participants in a Phase III study of its COVID-19 booster shot, while Global Access Diagnostics, Orbit Discovery, Proximie and more provide business and pipeline updates.

  June 15, 2022

   · 

  5 min read

   · 

  Alex Keown
• 

  Policy

  FDA Panel Unanimously Recommends Pfizer-BioNTech and Moderna Vaccines for Young Kids

  An FDA advisory committee voted Wednesday to recommend both the Pfizer-BioNTech and Moderna COVID-19 vaccines for children as young as six months old.

  June 15, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  MorphoSys Adds HIBio to Busy Collaboration Week

  MorphoSys is having a busy week after entering into an equity participation agreement with HIBio and a supply agreement and clinical collaboration with Pfizer and Incyte.

  June 15, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Acadia Surges After FDA Published Briefing Documents for Alzheimer’s-Related Psychosis Therapeutic

  Shares of Acadia are up more than 12% in early trading after the FDA published briefing documents related to its supplemental NDA for antipsychotic therapeutic.

  June 15, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Employer Resources

  BioSpace, BIO Reports Reflect Diversity Struggles in Biopharma

  Representation of women in biotech is nearing parity, but this is not reaching the executive level, where there is still stark disparity.

  June 15, 2022

   · 

  6 min read

   · 

  Hayley Shasteen